Figure 2: Outcomes with sacubitril/valsartan relative to enalapril.
Participants taking lower than target sacubitril/valsartan doses had a lower risk of the primary event compared with those taking similar doses of enalapril.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.